WealthPLAN Partners’s Teva Pharmaceuticals TEVA Stock Holding History

WealthPLAN Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28	Closed	-$211	–	1080
2023 Q2	$211	Hold	28	–	–	﹤0.01%	1211
2023 Q1	$248	Buy	+28	New	+$277	﹤0.01%	1271
2016 Q3	$22.2K	Sell	491 -653	-57%	-$34.1K	0.01%	466
2016 Q2	$24.7K	Buy	+1,144	New	+$60.9K	﹤0.01%	1296
2015 Q4	$92	Buy	+1,390	New	+$85.9K	﹤0.01%	1637

Other funds holding TEVA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Ion Asset Management Herzliya, Israel $818M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.04B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return